沉默ADAM17抑制肺癌细胞sMICA分泌促进NK细胞的抗肿瘤免疫效应

doi:10.3969/j.issn.1006-6233.2021.04.01

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1802 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的: 探讨沉默解聚素-金属蛋白酶17(ADAM17)抑制肺癌细胞可溶性主要组织相容性复合体Ⅰ类相关分子A(sMICA)的分泌对自然杀伤(NK)细胞的抗肿瘤免疫效应的影响。方法: 免疫组织化学法检测肺癌组织和癌旁组织中ADAM17的表达,实时定量聚合酶链反应法(qRT-PCR)检测肺癌细胞A549与人正常肺上皮细胞BEAS-2B中ADAM17的mRNA表达。小干扰RNA(siRNA)内源性敲低ADAM17,qRT-PCR检测ADAM17与主要组织相容性复合体Ⅰ类相关分子A(MICA)的mRNA表达,蛋白质免疫印迹法(Western blot)检测ADAM17与MICA的蛋白表达,酶联免疫吸附测定法(ELISA)检测A549细胞上清液sMICA的表达,流式细胞术检测MICA的表达,乳酸脱氢酶释放法检测NK细胞对肺癌细胞的杀伤敏感性。结果: ADAM17在肺癌组织及肺癌细胞A549中高表达。siRNA内源性敲低ADAM17,A549细胞上清中sMICA含量降低(P<0.05),A549细胞MICA表达升高(P<0.05),NK细胞对A549细胞的杀伤活性显著增强(P<0.05)。结论: 沉默ADAM17促进肺癌细胞MICA的表达,抑制sMICA的脱落,增强NK细胞对肺癌细胞的杀伤敏感性。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	彭非
	卢经伟
	李勇
	张艳霞

关键词 ： ADAM17, sMICA, MICA, NK细胞, 肺癌

Abstract：Objective: To investigate the effect of silenced disintegrin-metalloproteinase 17 (ADAM17) on the anti-tumor immune effect of natural killer (NK) cells by inhibiting the secretion of soluble major histocompatibility complex class I related molecule A (sMICA) of lung cancer cells.Methods: Immunohistochemistry was used to detect the expression of ADAM17 in lung cancer tissues and adjacent tissues. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the mRNA expression of ADAM17 in lung cancer cells A549 and human normal lung epithelial cells BEAS-2B. Small interfering RNA (siRNA) endogenously knocks down ADAM17, qRT-PCR detects the mRNA expression of ADAM17 and major histocompatibility complex class I related molecule A (MICA), Western blot detects ADAM17 and MICA The protein expression of NK cells was detected by enzyme-linked immunosorbent assay (ELISA) to detect the expression of sMICA in the supernatant of A549 cells, flow cytometry was used to detect the expression of MICA, and the lactate dehydrogenase release method was used to detect the killing sensitivity of NK cells to lung cancer cells. Results: ADAM17 was highly expressed in lung cancer tissues and lung cancer cell A549. siRNA endogenously knocked down ADAM17, the content of sMICA in the supernatant of A549 cells decreased (P<0.05), the expression of MICA in A549 cells increased (P<0.05), and the killing activity of NK cells on A549 cells was significantly enhanced (P<0.05). Conclusion: Silencing ADAM17 promotes the expression of MICA of lung cancer cells, inhibits the shedding of sMICA, and enhances the killing sensitivity of NK cells to lung cancer cells.

Key words： ADAM17 sMICA MICA NK cells Lung cancer

基金资助:湖北省卫生健康委科研立项项目,(编号:WJ2019Q022)

引用本文:

彭非, 卢经伟, 李勇, 张艳霞. 沉默ADAM17抑制肺癌细胞sMICA分泌促进NK细胞的抗肿瘤免疫效应[J]. 河北医学, 2021, 27(4): 529-534.
PENG Fei, LU Jingwei, LI Yong, et al. Promoting Antitumor Immune Effect of NK Cells by Inhibiting sMICA Secretion of Lung Cancer Cells with Silencing ADAM17. HeBei Med, 2021, 27(4): 529-534.

链接本文:

http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2021.04.01 或 http://www.hbyxzzs.cn/CN/Y2021/V27/I4/529

[1] Bade BC,Dela Cruz CS.Lung cancer 2020: epidemiology,etiology,and prevention[J].Clin Chest Med,2020,41(1):1~24.
[2] Ichihara E,Miyahara N,Maeda Y,et al.Managing lung cancer with comorbid interstitial pneumonia[J].Intern Med,2020,59(2):163~167.
[3] Dsterhoft S,Lokau J,Garbers C,et al.The metalloprotease ADAM17 in inflammation and cancer[J].Pathol Res Pract,2019,215(6):152410.
[4] Xing S,Zhu Y,Sun Y.Serum sMICA as biomarker in detection of non-small-cell lung carcinoma[J].Br Biomed Sci,2018,75(1):50~52.
[5] Arai J,Goto K,Tanoue Y,et al.Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells[J].Int Cancer,2018,143(10):2575~2583.
[6] Ruiz-Cordero R,Devine WP.Targeted therapy and checkpoint immunotherapy in lung cancer[J].Surg Pathol Clin,2020,13(1):17~33.
[7] Rosenthal R,Cadieux EL,Salgado R,et al.Neoantigen-directed immune escape in lung cancer evolution[J].Nature,2019,567(7749):479~485.
[8] Pockley AG,Vaupel P,Multhoff G.NK cell-based therapeutics for lung cancer[J].Expert Opin Biol Ther,2020,20(1):23~33.
[9] Ou ZL,Luo Z,Wei W,et al.Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ-0000977/miR-153 axis[J].RNA Biol,2019,16(11):1592~1603.
[10] Dusterhoft S,Lokau J,Garbers C.The metalloprotease ADAM17 in inflammation and cancer[J].Pathol Res Pract,2019,215(6):152410.
[11] Saad MI,McLeod L,Yu L,et al.The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis[J].Carcinogenesis,2020,41(4):527~538.
[12] Jun Arai,Kaku Goto,Yasushi Tanoue,et al.Enzymatic Inhibition of MICA Sheddase ADAM17 by Lomofungin in Hepatocellular Carcinoma Cells[J].Int Cancer,2018,143(10):2575~2583.
[13] Ou ZL,Luo Z,Wei W,et al.Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ-0000977/miR-153 axis[J].RNA Biol,2019,16(11):1592~1603.
[14] Oh S,Park Y,Lee HJ,et al.A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy[J].Cancers (Basel),2020,12(3):745.